Rational Basis of Antiarrhythmic Therapy: Clinical Pharmacology of Commonly Used Antiarrhythmic Drugs

Fozzard, H.A. , Beeler, G.W. : The voltage clamp in cardiac electrophysiology . Circ. Res., 37: 403-413, 1975.

Cranefield, P.F. : The Conduction of Cardiac Impulse. Mt. Kisco, New York, Futura Publishing Company, 1975.

Cranefield, P.F. , Wit, A.L. , Hoffman, B.F. : Genesis of cardiac arrhythmias. Circulation, 47: 190-204, 1973.

Rosen, M.R. , Hoffmann, B.F. : Mechanisms of action of antiarrhythmic drugs. Circ. Res., 32: 1-8, 1973.

Singh, B.N. , Hauswirth, O. : Comparative mechanisms of action of antiarrhythmic drugs. Am. Heart J., 87: 367-382, 1974.

Singh, B.N. : Recent advances in antiarrhythmic therapy. Prog. Cardiovasc. Dis. (in press).

Goldreyer, B.N. : Intracardiac electrocardiography in the analysis and understanding of cardiac arrhythmias. Ann. Intern. Med. , 77: 117-136, 1972.

Koch-Weser, J. , Klein, S.W. : Procainamide dosage schedules, plasma concentrations and clinical effects. J.A.M.A., 215: 1454-1460, 1971.

Thompson, P.D. , Melmon, K.L. , Richard-son, J.A. , et al.: Lidocaine pharmacokinetics in advanced heart failure, liver disease and renal failure in man. Ann. Intern. Med., 78: 499-508, 1973.

Winkle, A. , Glantz, A. , Harrison, D.C. : Pharmacologic therapy of ventricular arrhythmias. Am. J. Cardiol. , 36:629-650, 1975.

Fozzard, H.A. , Gibbons, W.R. : Action potential and contraction of heart muscle. Am. J. Cardiol., 31: 182-193, 1973.

Fozzard, H.A. : Cardiac muscle: Excitability and passive electrical properties. Prog. Cardiovasc. Dis., 19: 343-359, 1977.

Weidmann, S. : The effect of the cardiac membrane potential on the rapid availability of the sodium carrying system. J. Physiol. Lond., 127: 213-224, 1955.

Trautwein, W. : Membrane currents in cardiac muscle fibres . Physiol. Rev., 53: 793-831, 1973.

Zipes, D.P. , Fischer, J.C. : Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog. Circ. Res., 34: 184-196 1974.

Noble, D. : The Initiation of the Heart Beat. Oxford, Clarendon Press, 1975.

Surawicz, B. : Calcium responses ("calcium spikes"). Am. J. Cardiol., 33: 689-690, 1974.

Wellens, H.J.J. : Contribution of cardiac pacing to our understanding of the Wolff- Parkinson-White syndrome. Br. Heart J., 37: 231-241, 1975.

Jewitt, D.E. , Singh, B.N. : The role of beta-adrenergic blockade in myocardial infarction. Prog. Cardiovasc. Dis., 16: 421-438, 1974.

Han, J. , Moe, G.K. : Non-uniform recovery of excitability in ventricular muscle. Circ. Res., 14: 44-50, 1964.

Vincent, G.V. , Abildskov, J.A. , Burgess, M.J. : Q-T interval syndromes. Prog. Cardiovasc. Dis., 16: 523-530, 1974.

Vaughan Williams, E.M. : Electrophysiological aspects of the action of antiarrhythmic drugs. Proc. R. Soc. Med., 62: 75-77, 1969.

Bigger, J.T. , Jr., Mandel, W.J. : Effect of lidocaine on conduction in canine Purkinje fibers and at the ventricular muscle-Purkinje fiber junction. J. Pharmacol. Exp. Ther., 174: 487-499, 1970.

Singh, B.N. , Vaughan Williams, E.M. : Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit and ventricular muscle. Circ. Res., 29: 286-297, 1971.

Rosen, M.R. , Gelband, H. , Hoffman, B.F. : Effects of blood perfusion on electrophysiological properties of isolated canine Purkinje fibres. Circ. Res. , 30: 575- 582, 1972 .

Rosen, M.R. , Merker, C. , Pippenger, C.E. : The effects of lidocaine on the canine ECG and electrophysiological properties of Purkinje fibers. Am. Heart J., 91: 191-202, 1976.

Rosen, M.R. , Danilo, P. , Alonso, M.B. , et al.: Effects of therapeutic concentrations of diphenyldantoin on transmembrane potentials of normal and depressed Purkinje fibers. J. Pharmacol. Exp. Ther. 197: 594- 604, 1976.

Freedberg, A.S. , Papp, J.G. , Vaughan Williams , E.M. : The effect of altered thyroid state on atrial intracellular potentials. J. Physiol. , 207: 357-363, 1970.

Singh, B.N. , Vaughan Williams , E.M. : The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br. J. Pharmacol. , 39: 657-668, 1970.

Vastesaeger, M. , Gillot, P. , Rasson, G. : Etude clinique d'une nouvelle medication anti-angoreuse. Acta Cardiol., 22: 483-490, 1967.

Rosenbaum, M.B. , Chiale, P.A. , Ryba, D. , et al.: Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am. J. Cardiol., 34: 215-222, 1974.

Cranefield, P.F. , Aronson, R.S. , Wit, A.L. : Effect of verapamil on the normal action potential and on a calcium-dependent slow response of canine cardiac Purkinje fibers. Circ. Res., 34: 204-213, 1974.

Singh, B.N. , Vaughan Williams , E.M. : A fourth class of antidysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials and on other features of cardiac function. Cardiovasc. Res., 6: 109-114, 1972.

Heng, M.K. , Singh, B.N. , Roche, A.H.G. , et al.: Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. Am. Heart J., 90: 487- 498, 1975.

Singh, B.N. : Antiarrhythmic effects of local anesthetics and calcium antagonists. Pharmacol. Ther., 2: 125-150, 1977.

Singh, B.N. , Ellrodt, G. , Peter, C.T. : The pharmacological effects and therapeutic applications of verapamil. Drugs (in press).

Vaughan Williams, E.M. : The mode of action of quinidine on isolated rabbit atria interpreted from intracellular records. Br. J. Pharmacol., 13: 276-287, 1958.

Watanabe, Y. , Dreifus, L.S. : Interactions of quinidine and potassium on atrioventricular transmission. Circ. Res., 20: 434-446, 1967.

Conn, H.L. : Some considerations of quinidine and procainamide action at the cellular level . In The Myocardial Cell. Edited by S. A. Briller , H. L. Conn. Philadelphia, University of Pennsylvania Press, 1966, pp. 269-296.

Heissenbuttel, R.H. , Bigger, J.T. : The effect of oral quinidine on intraventricular conduction in man: Correlation of plasma quinidine with changes in QRS duration . Am. Heart J., 80: 453-462, 1970.

Krikler, D.M. , Curry, P.V.L. : Torsade de pointes, an atypical ventricular tachycardia. Br. Heart J., 38: 117-120, 1976.

Selzer, A. , Wray, H.W. : Quinidine syncope: Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial fibrillation. Circulation, 30: 17-26, 1964.

Conn, H.L. , Luchi, R.J. : Some cellular and metabolic considerations relating to the action of quinidine as a prototype antiarrhythmic agent. Am. J. Med., 37: 685- 699, 1964.

Greenblatt, J.D. , Wu, E. : Pharmacokinetic studies with short and long acting quinidine preparations. Angiology (in press).

Kessler, K.M. , Lowenthal, D.T. , Warner, H. : Quinidine elimination in patients with congestive heart failure or poor renal function. N. Engl. J. Med., 290: 706-709, 1974.

Byrne-Quinn, E. , Wing, A.J. : Maintenance of sinus rhythm after DC reversion of atrial fibrillation. Br. Heart J., 32: 370-376, 1970.

Chung, E.K. : Digitalis intoxication. Postgrad. Med. J., 48: 163-179, 1972.

Lown, B. , Wolf, M. : Approaches to sudden death from coronary heart disease. Circulation , 44: 130-142, 1970.

Fors, W.J. , VanderArk, C. R., Reynolds, E. W.: Evaluation of propranolol and quinidine in the treatment of quinidine-resistant arrhythmias. Am. J. Cardiol., 27: 190-194, 1971.

Torok, E. , Bajkay, G. , Gulyas, A. , et al.: Comparative study of a long acting quinidine preparation and quinidine sulphate in chronic and fibrillation. Pharmacol. Clin. 2: 90-93, 1970.

Rosen, M.R. , Gelband, H. , Hoffman, B.F. : Canine electrocardiographic and cardiac electrophysiologic changes induced by procainamide. Circulation , 46: 528-536, 1972.

Josephson, M.E. , Caracta, A.R. , Ricciutti, M.A. , et al.: Electrophysiologic properties of procainamide in man. Am. J. Cardiol., 33: 596-603, 1974.

Helfant, R.H. , Scherlag, B.J. , Damato, A.N. : The electrophysiological properties of diphenylhydantoin sodium as compared to procainamide in the normal and digitalis-intoxicated dog. Circulation, 36: 108-118, 1967.

Helfant, R.H. , Scherlag, B.J. , Damato, A.N. : Use of diphenyldantoin sodium to dissociate the effects of procainamide on automaticity and conduction in the normal and arrhythmic heart. Am. J. Cardiol., 20: 820-825, 1967.

Koch-Wester, J. : Pharmacokinetics of procainamide in man. Ann. N. Y. Acad. Sci., 179: 370-382, 1971.

Giardina, E.G.V. , Heissenbuttel, R.H. , Bigger, J.T. : Intermittent intravenous procainamide to treat ventricular arrhythmias. Ann. Intern. Med., 78: 183-193, 1973.

Weiley, H.S. , Genton, E. : Pharmacokinetics of procainamide. Arch. Intern. Med., 130: 366-369, 1972.

Singh, B.N. : Side effects of antiarrhythmic drugs. Pharmacol. Ther., 2: 151-166, 1977.

Dubois, E.L. : Procainamide induction of a systemic lupus erythematosus syndrome. Presentation of six cases, review of the literature and analysis and follow up of reported cases. Medicine, 48: 217-228, 1969.

Jewitt, D.E. , Kishon, Y. , Thomas, M. : Lignocaine in the management of arrhythmias after acute myocardial infarction. Lancet, 1: 266-270, 1968.

Gianelly, R. , Von der Groeben, J.O. , Spivack, D. , et al.: Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N. Engl. J. Med., 277: 1215-1219, 1967.

Strong, J.M. , Parker, M. , Atkinson, A.J. , Jr.: Identification of glycinexylidide in patients treated with intravenous lidocaine. Clin. Pharmacol. Exp. Ther., 14: 67-72, 1973.

Stenson, R.E. , Constantino, R.T. , Harrison, D.C. : Interrelationships of hepatic blood flow, cardiac output and blood levels of lidocaine in man. Circulation , 41: 205-211, 1971.

Wit, A.L. , Friedman, P.L. : Basis for arrhythmias accompanying myocardial infarction. Arch. Intern. Med., 135: 459-471, 1975.

Moe, G.K. , Mendez, C. : The physiological basis of reciprocal rhythm. Prog. Cardiovasc. Dis., 8: 461-482, 1966.

Thompson, P.D. , Rowland, M. , Melmon, K.L. : The influence of heart failure, liver disease and renal failure on the disposition of lidocaine in man. Am. Heart J., 82: 417-421, 1971.

Rosen, K. , Lau, S.H. , Weiss, M. , et al.: The effect of lidocaine on atrioventricular and intraventricular conduction in man. Am. J. Cardiol., 25: 1-5, 1971.

Lichstein, E. , Chudda, K.D. , Gupta, P.K. : Atrioventricular block with lidocaine therapy . Am. J. Cardiol., 31: 277-281, 1973.

Marriott, H.J. , Bieza, C.F. : Alarming ventricular acceleration after lidocaine administration. Chest, 61: 682, 1972.

Strauss, H.C. , Bigger, J.T. , Basset, A.L. , et al.: Actions of diphenylhydantoin on the electrical properties of isolated rabbit and canine atria. Circ. Res., 23: 463-477, 1968.

Bigger, J.T. , Schmidt, D.H. , Kutt, H. : Relationship between plasma level of diphenylhydantoin and its cardiac antiarrhythmic effects. Circulation, 38: 363-374, 1968.

Rosen, M.R. , Liasak, R. , Rubin, I.L. : Diphenylhydantoin in cardiac arrhythmias . Am. J. Cardiol., 20: 674-680, 1967.

Ward, M. , Mather, J.A. : Diphenylhydantoin intoxication mimicking botulism. N. Engl. J. Med., 286: 88-90, 1971.

Danilo, P. , Rosen, M.R. : Cardiac effects of disopyramide. Am. Heart J., 92: 532-536, 1976.

Befeler, B. , Castellanos, A. , Wells, D.E. , et al.: Electrophysiological effects of the antiarrhythmic agent disopyramide phosphate. Am. J. Cardiol. , 35: 282-287, 1974.

Singh, B.N. : Unpublished observations, 1977.

Marriott, P.K. , Ruttley, M.S.T. , Winterbottam , J.T. , et al.: A study of the acute electrophysiological and cardiovascular action of disopyramide in man. Europ. J. Cardiol., 4: 303-312, 1976.

Jensen, G. , Sigurd, B. , Uhrenhott, A. : Hemodynamic effects of intravenous disopyramide in heart failure. Eur. J. Clin. Pharmacol., 8: 167-173, 1975.

Conway, J.F. , Bottomley, K. , Wakely, E.J. , et al.: Disopyramide in cardiac arrhythmias—An initial appraisal. J. Int. Med. Res., 1: 105-114, 1973.

Vismara, L.A. , Mason, D.T. , Amsterdam, E.A. : Disopyramide phosphate: Clinical efficacy of a new oral antiarrhythmic drug. Ther., Pharmacol. Exp. Ther., 16: 330-335, 1974.

Jennings, G. , Model, D.G. , Jones, M.B.S. , et al.: Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Lancet, 1: 51-54, 1976.

Zainal, N. , Carmichael, D.J.S. , Griffiths, J.W. , et al.: Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. Lancet, 2: 887-889, 1977.

Spurrell, R.A.J. , Thorburn, C.W. , Camm, J. , et al.: Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in WPW syndrome. Br. Heart J., 37: 861-867, 1975.

Karim, A. : The pharmacokinetics of norpace. Angiology, 26: 85-95, 1975.

Conolly, M.E. , Kersting, F. , Dollery, C.T. : The clinical pharmacology of beta- adrenoceptor-blocking drugs. Prog. Cardiovasc. Dis., 19: 203-234, 1977.

Singh, B.N. , Jewitt, D.E. : Beta-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs, 7: 426-461, 1974.

Shand, D.G. : Individualization of propranolol therapy. Med. Clin. North Am., 58: 1063-1069, 1975 .